Sekisui Chemical Co., Ltd. · TSE:4204
Sekisui Chemical — Q2 2025 Earnings Presentation
48 slides from Sekisui Chemical's earnings presentation, Oct 30, 2025
Slide 1: Presentation of Financial Results Progress under Management Plan
SEKISUI CHEMICAL CO., LTD. For 2Q FY2025, ending March 31, 2026 Presentation of Financial Results Progress under Management Plan Keita Kato President and CEO October 30, 2025
Slide 2: Main Points of Today's Presentation
Main Points of Today’s Presentation ★：Record high Compared Difference 2H Compared Difference Compared 1H FY2025 Difference with from FY2025 with from with FY2025 Revised from Plan 1H FY2024 Forecasts Revised 2H FY2024 Forecasts FY2024 (JPY billion) Results Plan (Apr. 2025) Results (July 2025) Plan R
Slide 3: Overview of the Perovskite Solar Cell Business
Overview of the Perovskite Solar Cell Business ▌ Acquisition of the site at Sharp Corporation’s Sakai Plant with steps initiated to install equipment; operations of a 100 MW production line scheduled to commence in 2027 ▌ Plans to commence sales on a commercial basis in March 2026 ▌ Accelerate devel
Slide 4: Results for 1H FY2025
Results for 1H FY2025 1H 1H FY2025 Forex rate FY2024 FY2025 Initial Plan In-house ¥145/US$ ¥152/US$ assumptions - ¥165/€ ¥159/€ Results (Avg. rate for ¥153/US$ ¥146/US$ - Tatsuya Nishida each term) ¥166/€ ¥168/€ Managing Executive Officer * Export data is subject to in-house assumptions regarding fo
Slide 5: Overview of 1H FY2025 Results
Overview of 1H FY2025 Results ▌ Despite falling below forecasts (July) due to continued weak market conditions, increase in net sales to a record high ▌ Operating profit falling below of forecasts (July) ▌ Increase in ordinary profit on the back of foreign exchange gains; decrease in the bottom line
Slide 6: 1H FY2025 Results by Segment
1H FY2025 Results by Segment ▌ Increase in operating profit in the Housing Company unable to offset downturns in the HPP Company and Medical Business; despite an increase in Group-wide net sales, decrease in operating income ▌ Results significantly impacted by continued weak market conditions in Jap
Slide 7: 1Q & 2Q FY2025 Results by Segment
1Q & 2Q FY2025 Results by Segment ▌ Despite a decline owing to net sales brought forward to the 1Q, 2Q operating profit in the Housing Company exceeded forecasts (July) 1Q FY2024 1Q FY2025 2Q FY2024 2Q FY2025 Net Operating Net Operating Net Operating Net Operating (JPY billion) sales profit sales pr
Slide 8: 1H FY2025 Results Analysis
1H FY2025 Results Analysis ▌ Impacted significantly by partial stagnation in the motive market and a continued slump in domestic and overseas market conditions, sales volumes and product mix deteriorated; efforts made to improve selling prices and raw materials while controlling fixed costs; despite
Slide 9: FY2025: Revised 2H and Full FY Plans
FY2025: Revised 2H and Full FY Plans 2H FY2025 FY2025 Forex rate 2H FY2024 Revised Plan Initial Plan In-house ¥148/US$ ¥152/US$ assumptions - ¥172/€ ¥159/€ Results ¥153/US$ (Avg. rate for - - each term) ¥162/€ * Export data is subject to in-house assumptions regarding foreign currency exchange rates
Slide 10: Outlook for Market Conditions
Outlook for Market Conditions *Figures in parentheses: 1H forecasts (July) Housing・Visitors (YoY) Number of Automobiles Manufactured (YoY) 2H plans (April) Substantial decline in exhibition visitors in the 1H, overall visitor 2Q trends in line with forecasts (July) and slightly below the previous tr
Slide 11: 2H FY2025 Revised Plan by Segment
2H FY2025 Revised Plan by Segment ▌ Increase in net sales in three segments, excluding the Medical Business, as well as Group-wide; increase in operating profit in all segments; target record high net sales and operating profit ▌ Despite net sales falling below plans (April), operating profit foreca
Slide 12: 2H FY2025 Revised Plan Analysis
2H FY2025 Revised Plan Analysis ▌ Despite little likelihood of a recovery from weak market conditions and a substantial decline in sales volumes, projecting improvements in product mix on the back of high-performance product sales growth as well as improvements in selling prices and raw materials; c
Slide 13: FY2025 Revised Plan by Segment
FY2025 Revised Plan by Segment ▌ Plans for an increase in net sales and operating profit in three segments, excluding the Medical Business, as well as Group-wide; target record highs FY2025 FY2025 FY2024 Difference Difference Revised Plan Plan (Apr.) Net Operating Net Operating Net Operating Net Ope
Slide 14: FY2025 Revised Plan and Returns to Shareholders
FY2025 Revised Plan and Returns to Shareholders ▌ Plans for an increase in both net sales and operating profit to record highs ▌ While ordinary profit is projected to increase, bottom line forecast to decline owing to a downturn in the gain on sale on cross-shareholdings ▌ Dividend per share in line
Slide 15: Consolidated Performance
Consolidated Performance ▌ Strengthening earning power; continuing preparations and growth toward the next Medium-term Plan (JPY billion) EBITDA 119.3 126.7 133.4 137.7 137.3 133.2 116.6 137.6 142.1 147.1 161.7 169.5 175.0 1,410.0 1,297.8 1,323.2 1,242.5 1,256.5 1,157.9 1,112.7 1,096.3 1,107.4 1,142
Slide 16: High Performance Plastics Company
High Performance Plastics Company Akira Asano Company President 15
Slide 17: FY2025 1H Results and 2H Revised Plan
HPP FY2025 1H Results and 2H Revised Plan Company ▌ 1H: Firm trends in each of the Electronics and Industrial fields; in the Mobility field, EV market growth and recovery in Europe and the U.S. slower than expected; results below forecasts (July) ▌ 2H: Trends in the Electronics and Industrial fields
Slide 18: 1H FY2025 Results Analysis
HPP 1H FY2025 Results Analysis Company ▌ Weak trends in designed films and a deterioration in sales volumes and product mix owing to the impact of sluggish EV market growth ▌ Posted a one-off expense relating to a resin material transaction dispute in Europe ▌ Improvement in selling prices; despite
Slide 19: 2H FY2025 Revised Plan Analysis
HPP 2H FY2025 Revised Plan Analysis Company ▌ Despite continued deterioration in sales volumes and product mix in the 1H, forecasting further growth for HUDs ▌ Targeting increases in net sales and operating profit on the back of an upswing in aircraft demand, improvements in selling prices and raw m
Slide 20: Three Strategic Fields
HPP Three Strategic Fields Company Net Sales Trends and KPIs in the Three Strategic Fields Growth Growth 11 businesses clarified as strengthening the current PF driving potential in the Drive 2.0 Medium-term Management Plan. Electronics Mobility Electronics (semiconductor and Mobility (high-performa
Slide 21: Housing Company
Housing Company Masahide Yoshida Company President 20
Slide 22: FY2025 1H Results and 2H Revised Plan
Housing FY2025 1H Results and 2H Revised Plan Company ▌ 1H: Despite weak new housing market conditions, increase in net sales and substantial upswing in operating profit owing to higher unit prices on the back of improvements in the product mix and order growth in the Renovation Business ▌ 2H: Plans
Slide 23: 1H FY2025 Results Analysis
Housing 1H FY2025 Results Analysis Company ▌ Product mix, cost reductions, and cuts in fixed costs offset the decrease in the number of houses sold compared with forecasts (July) in the Housing Business; secured an increase in operating profit ▌ Increase in net sales and substantial upswing in opera
Slide 24: 2H FY2025 Revised Plan Analysis
Housing 2H FY2025 Revised Plan Analysis Company ▌ While market conditions in the Housing Business are not expected to recover in the 2H, targeting a substantial increase in operating profit on the back of ongoing higher unit prices owing to improvements in the product mix and growth in the Renovatio
Slide 25: KPIs by Business and Measures to Strengthen Profitability
Housing KPIs by Business and Measures to Strengthen Profitability Company Housing Business <Amount of Orders and the Number of (YoY) New Housing Orders (YoY) Buildings by Type of Construction> Orders by Unit Price and Price Range • 1H: Amount of orders came in in line with plans owing • Upward trend
Slide 26: Urban Infrastructure & Environmental Products Company
Urban Infrastructure & Environmental Products Company Yoshiyuki Hirai Company President 25
Slide 27: FY2025 1H Results and 2H Revised Plan
UIEP FY2025 1H Results and 2H Revised Plan Company ▌ 1H: Despite maintaining margins with the growing acceptance of new prices, decrease in net sales and operating profit owing to the substantial impact of weak market conditions ▌ 2H: While weak market conditions are forecast to linger, target an in
Slide 28: 1H FY2025 Results Analysis
UIEP 1H FY2025 Results Analysis Company ▌ Despite the growing acceptance of new prices and efforts to control fixed costs, net sales and operating profit came in below forecasts (July) owing to a downturn in construction site work due to the extreme heat • Japan: Despite weak housing and non-residen
Slide 29: 2H FY2025 Revised Plan Analysis
UIEP 2H FY2025 Revised Plan Analysis Company ▌ Market conditions expected to roughly mirror those of the 1H; target record-high operating profit in the 2H and full FY by strictly securing margins and expanding sales volumes and product mix focusing on growth-driving businesses • Japan: Focus on expa
Slide 30: Three Strategic Fields
UIEP Three Strategic Fields Company Net sales in the Three Strategic Fields and KPI’s Building and Performance Construction and Fire resistant and non- Pipe Systems flammable materials materials (railroad industrial piping Infrastructures Composite Materials sleepers, etc.) • 1H: (Piping materials)
Slide 31: Medical Business
Medical Business Hiroyuki Yamashita President of SEKISUI MEDICAL CO., LTD 30
Slide 32: FY2025 1H Results and 2H Revised Plan
Medical FY2025 1H Results and 2H Revised Plan Business ▌ 1H: Decrease in net sales and operating profit owing to sluggish overseas diagnostic demand and market conditions ▌ 2H: Despite an ongoing harsh overseas diagnostics environment, target an increase in operating profit on the back of efforts to
Slide 33: 1H FY2025 Results Analysis
Medical 1H FY2025 Results Analysis Business ▌ Decreases in demand for priority infectious disease testing kits in the U.S. and product shipments to major customers; continued weak market conditions in China; despite efforts to control fixed costs, decrease in net sales and operating profit; results
Slide 34: 2H FY2025 Revised Plan Analysis
Medical 2H FY2025 Revised Plan Analysis Business ▌ Weak priority infectious disease testing kit demand and continued harsh market conditions in China ▌ Upswing in the Pharmaceutical Sciences Business and efforts to control fixed costs; Despite decrease in net sales ,increase in operating profit ; ta
Slide 35: Overview by Business
Medical Overview by Business Business Net sales by Business and Overview of Progress Overseas testing Diagnostics (Japan) Diagnostics (overseas) system • 1H: The outbreak of priority infectious diseases below expectations • 1H: Delayed influenza outbreak in the U.S. • 2H: Continue to capture testing
Slide 36: Financial Results 1H FY2025
Financial Results 1H FY2025 35
Slide 37: Number and Impact of Changes in Consolidated Companies
Number and Impact of Changes in Consolidated Companies Number of Consolidated Companies Mar. 31, 2025 Sep. 30, 2025 Difference Consolidated Increased: 2 Subsidiaries*1 subsidiaries 145 144 Decreased: 3 Subsidiaries*2 Affiliates Increased: 0 Subsidiaries 6 6 (Equity Method) Decreased: 0 Subsidiary *1
Slide 38: Summary of Profit and Loss
Summary of Profit and Loss + 1H FY2024 1H FY2025 Difference (JPY billion) Net sales 629.1 629.8 +0.7 Gross profit 202.8 203.0 +0.1 Foreign exchange losses: -4.1 Gross profit margin 32.2% 32.2% 0 Selling, general and administrative expenses 154.1 157.5 +3.4 Foreign exchange losses: -1.0 Operating pro
Slide 39: Balance Sheets (Assets)
Balance Sheets (Assets) Sep.30 Inventories (B/S item) 2025 Difference Ready-built housing (products) 33.5 +0.2 Prepared land for subdivision Mar. 31, 2025 Sep. 30, 2025 Difference housing 75.5 +6.3 (JPY billion) Land under preparation (work in process) 8.4 -1.3 Housing under construction Cash and de
Slide 40: Balance Sheets (Liabilities & Net Assets)
Balance Sheets (Liabilities & Net Assets) Green Bond: +20.0 (JPY billion) Mar. 31, 2025 Sep. 30, 2025 Difference Non-interest-bearing liabilities 384.6 378.0 +4.8 Interest-bearing liabilities 110.8 131.6 +20.8 Net profit: +31.7 [Net interest-bearing liabilities] [-31.8] [-15.9] [+15.8] Dividends pai
Slide 41: Consolidated Cash Flows
Consolidated Cash Flows 1H FY2024 1H FY2025 (JPY billion) Cash flows from operating activities 58.3 49.8 Cash flows from investing activities -13.9 -19.9 Cash flows from financing activities -37.8 -12.0 Net increase in cash and cash equivalents 4.4 20.6 Free cash flow =Cash flows from operating acti
Slide 42: Depreciation, Amortization, Capital Expenditures and EBITDA
Depreciation, Amortization, Capital Expenditures and EBITDA Goodwill and other Depreciation*1 Capital expenditures EBITDA*3 amortization*2 1H 1H Differ- 1H 1H Differ- 1H 1H Differ- 1H 1H Differ- FY2024 FY2025 ence FY2024 FY2025 ence FY2024 FY2025 ence FY2024 FY2025 ence (JPY billion) Housing 5.6 5.6
Slide 43: Depreciation, Amortization, Capital Expenditures, Research and Development Expenditure
Depreciation, Amortization, Capital Expenditures, Research and Development Expenditure FY2025 FY2024 Difference (JPY billion) Revised Plan Depreciation 51.1 57.3 +6.2 Goodwill and other amortization 2.6 2.2 -0.4 Capital expenditures 70.3 105.0 +34.7 EBITDA 161.7 ★169.5 +7.8 Research and development
Slide 44: This slide presentation contains forward-looking statements.
This slide presentation contains forward-looking statements. These statements are based on current expectations and beliefs. However, actual results may differ from those expressed or implied due to a number of factors and uncertainties such as changes in the global economy and our business, competi
Slide 45: Housing Company Results and Plan
Housing Company Results and Plan 1. Main data in Housing business 5ｚｚｚｚｚｚｚｚｚｚｚｚｚ FY2025 FY2024 2H Revised 1H Annual Plan 1H 2H Annual Plan Net sales (JPY billion) 258.6 273.8 532.4 253.7 270.4 524.0 167.1 172.2 339.3 165.2 172.2 337.3 CONSOLIDATED Housing Renovation 56.3 58.4 114.6 53.8 53.4 107.2 R
Slide 46: Various Performance Data
Various Performance Data Group-wide FY2025 FY2024 FY2023 FY2022 ■Net Sales (JPY billion) 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q HPP 108.2 115.3 - - 110.6 110.5 112.0 114.2 96.1 104.2 106.0 106.6 99.1 102.4 97.9 97.0 Housing 128.4 130.3 - - 116.2 137.4 132.0 138.4 121.0 143.8 126.7 138.1 115
Slide 47: Various Performance Data
Various Performance Data Industrial field FY2025 FY2024 FY2023 FY2022 ■Net Sales (JPY billion) 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q Labor-saving product 6.4 6.6 - - 5.9 5.9 5.9 7.0 4.9 5.2 4.8 5.6 6.0 5.6 4.8 5.3 Environmentally friendly product 1.8 2.1 - - 1.9 1.9 2.2 2.2 1.7 2.1 2.0 2.2
Slide 48: SEKISUI
SEKISUI Copyright© SEKISUI CHEMICAL CO., LTD.